SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Mark Twain Synthetic CCD

PatientSamuel Langhorne Clemens
Date of birth1956-11-30
IdentifiersMRN HR-NI013-SYN; SSN (made up) 000-13-2964
Document date2026-11-01
AuthorWinifred Achterberg-Lowe, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing primary care a year after his wife's death: yearning, poor sleep, low mood and withdrawal, suicide risk, heavy cigar smoking, chest tightness on hills, gout and cardiovascular risk. Concerns: He says the year since his wife died has not softened anything, and he wants to be able to work and see his friends again; He does not want to give up cigars, which he says help him write, but worries about his heart; He wants the gout attacks to stop. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four daysOne tablet daily on days 1 to 3, then twice daily on days 4 to 7Oral route2026-07-17 to 2026-07-24completedS
Varenicline 1 mg oral tablet, one tablet twice daily with food for twelve weeks, with a quit date in the second weekOne tablet twice daily with foodOral route2026-07-24activeS
Atorvastatin 40 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-07-17activeS
Aspirin 81 mg delayed-release oral tablet, one tablet dailyOne tablet dailyOral route2026-07-17activeS
Allopurinol 100 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-07-17 to 2026-09-11completedS
Allopurinol 100 mg oral tablet, two tablets daily (200 mg)Two tablets dailyOral route2026-09-11 to 2026-10-16completedS
Allopurinol 300 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-10-16activeS
Colchicine 0.6 mg oral tablet, one tablet daily for flare prevention while allopurinol is started, for three to six monthsOne tablet dailyOral route2026-07-17activeS
Prednisone 20 mg oral tablet, two tablets (40 mg) each morning for five days, for a gout flare, prescribed by a doctor where he was stayingTwo tablets each morning for five daysOral route2026-08-12 to 2026-08-16completedS

Procedures

ProcedureDatesStatusEvidence
Resting 12-lead electrocardiogram: sinus rhythm at 80 per minute, normal axis and intervals, no Q waves or ST-segment changes2026-06-12 to 2026-06-12completedS
CT coronary angiography with calcium scoring: coronary calcium score 410; 25 to 49 percent narrowing of the proximal left anterior descending artery from mixed plaque (CAD-RADS 2); no obstructive disease2026-07-17 to 2026-07-17completedS
Advance care planning conversation, about 20 minutes2026-09-25 to 2026-09-25completedS

Immunizations

DateVaccineStatusEvidence
2026-09-25High-dose influenza vaccine for the coming seasoncompletedS
2026-09-25Pneumococcal conjugate vaccine (PCV20); no earlier pneumococcal vaccinecompletedS
2026-10-16RSV vaccine, single dose, for an adult aged 60 to 74 with coronary diseasecompletedS
2026-10-16Recombinant zoster vaccine, first of two dosescompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
June 1872Death of his son at about two, from diphtheriaD (CLM-0004)
1894 to 1896Bankruptcy after the failure of his publishing company, followed by a worldwide lecture tour to repay his debtsD (CLM-0005)
about 1894 and 1897Gout: a first attack in Paris and a further attack in Vienna three years laterD (CLM-0010)
August 1896Death of his eldest daughter at 24, from meningitisD (CLM-0006)
June 5, 1904Death of his wife after 22 months of illness, a year before the index visitD (CLM-0007)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
He says the year since his wife died has not softened anything, and he wants to be able to work and see his friends againactiveS
He does not want to give up cigars, which he says help him write, but worries about his heartactiveS
He wants the gout attacks to stopactiveS

Assessment

Most recent measures: Leukocytes [#/volume] in Blood by Automated count 8.1 on 2026-06-12; Hemoglobin [Mass/volume] in Blood 15.6 on 2026-06-12; Platelets [#/volume] in Blood by Automated count 232 on 2026-06-12; Sodium [Moles/volume] in Serum or Plasma 140 on 2026-10-16; Potassium [Moles/volume] in Serum or Plasma 4.4 on 2026-10-16; Creatinine [Mass/volume] in Serum or Plasma 1.09 on 2026-10-16; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 73 on 2026-10-16; Glucose [Mass/volume] in Serum or Plasma 96 on 2026-10-16; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 28 on 2026-09-11; Urate [Mass/volume] in Serum or Plasma 6.4 on 2026-10-16; Hemoglobin A1c/Hemoglobin.total in Blood 5.8 on 2026-06-12; Cholesterol [Mass/volume] in Serum or Plasma 156 on 2026-09-11; Cholesterol in HDL [Mass/volume] in Serum or Plasma 46 on 2026-09-11; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 74 on 2026-09-11; Triglyceride [Mass/volume] in Serum or Plasma 180 on 2026-09-11; Thyrotropin [Units/volume] in Serum or Plasma 2.2 on 2026-06-12; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 410 on 2026-06-12; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 on 2026-10-16; Total score [AUDIT-C] 3 on 2026-06-12; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 on 2026-09-25; Total score [Mini-Cog] 5 on 2026-09-25 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Persistent yearning for his wife, broken sleep, low mood and withdrawal from friends and work, a year after her death; cause under evaluationresolvedconfirmed Z63.4S — Synthetic presenting problem anchored to his wife's documented death a year before; resolved into the diagnosis of prolonged grief disorder at the consultation. Not a claim about his real grief.
Prolonged grief disorder (DSM-5-TR): more than 12 months after his wife's death, daily yearning and preoccupation with her, with intense emotional pain, a sense that part of himself has died, avoidance of reminders, loneliness, difficulty taking up his work and life again, and a feeling that life is meaningless; PG-13-R 41; major depression not presentactiveconfirmed F43.81S — Synthetic modern diagnosis made at the consultation, anchored to his documented bereavements. Not a claim about his real mental health; the roster's bipolar lead is not used.
Tobacco use disorder, cigars: about fifteen cigars a day, smoking since boyhood, some smoke inhaled; first cigar within thirty minutes of wakingactiveconfirmed F17.290S — Synthetic modern coding anchored to his documented smoking since boyhood.
Chest tightness on climbing steep hills, twice in the past month, easing within five minutes of rest; none at rest; cause under evaluationresolvedconfirmed R07.89S — Synthetic presenting symptom; resolved into a diagnosis at five weeks after CT coronary angiography. Not a claim about his real heart in 1905; his documented chest pain began in 1909.
Coronary artery disease, nonobstructive (CAD-RADS 2: 25 to 49 percent narrowing of the proximal left anterior descending artery; coronary calcium score 410), with exertional chest tightness that has not recurred on treatment; treated with a statin, aspirin and stopping smokingactiveconfirmed I25.10S — Synthetic modern diagnosis made at five weeks. Not a claim about his real coronary arteries.
Gout, recurrent flares of the big toe since his late fifties, two in the past year; serum urate 8.6 mg/dL; no tophiactiveconfirmed M10.9S — Synthetic modern diagnosis anchored to his documented gout.
Acute bronchitis, likely viral, for six days in a cigar smoker; no pneumonia on examination; resolved within three weeks without antibioticsresolvedconfirmed J20.9S — Synthetic acute illness; not a historical claim; his documented bronchitis was in later years.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-12Leukocytes [#/volume] in Blood by Automated count8.110*3/uL4-11 10*3/uLNormalS
2026-06-12Hemoglobin [Mass/volume] in Blood15.6g/dL13.5-17.5 g/dLNormalS
2026-06-12Platelets [#/volume] in Blood by Automated count23210*3/uL150-400 10*3/uLNormalS
2026-06-12Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-06-12Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
2026-06-12Creatinine [Mass/volume] in Serum or Plasma1.08mg/dL0.74-1.35 mg/dLNormalS
2026-06-12Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M74mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-06-12Glucose [Mass/volume] in Serum or Plasma101mg/dL70-99 mg/dLHighS
2026-06-12Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L7-56 U/LNormalS
2026-06-12Urate [Mass/volume] in Serum or Plasma8.6mg/dL3.5-7.2 mg/dLHighS
2026-06-12Hemoglobin A1c/Hemoglobin.total in Blood5.8%<=5.6%HighS
2026-06-12Cholesterol [Mass/volume] in Serum or Plasma228mg/dL<=199 mg/dLHighS
2026-06-12Cholesterol in HDL [Mass/volume] in Serum or Plasma44mg/dL>=40 mg/dLNormalS
2026-06-12Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation150mg/dL<=99 mg/dLHighS
2026-06-12Triglyceride [Mass/volume] in Serum or Plasma170mg/dL<=149 mg/dLHighS
2026-06-12Thyrotropin [Units/volume] in Serum or Plasma2.2m[IU]/L0.4-4.5 mIU/LNormalS
2026-06-12Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma410pg/mL200-900 pg/mLNormalS
2026-06-12Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]11{score}S
2026-06-12Total score [AUDIT-C]3{score}S
2026-07-17Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S
2026-09-11Cholesterol [Mass/volume] in Serum or Plasma156mg/dL<=199 mg/dLNormalS
2026-09-11Cholesterol in HDL [Mass/volume] in Serum or Plasma46mg/dL>=40 mg/dLNormalS
2026-09-11Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation74mg/dL<=99 mg/dLNormalS
2026-09-11Triglyceride [Mass/volume] in Serum or Plasma180mg/dL<=149 mg/dLHighS
2026-09-11Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma28U/L7-56 U/LNormalS
2026-09-11Urate [Mass/volume] in Serum or Plasma7.4mg/dL3.5-7.2 mg/dLHighS
2026-09-11Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-09-11Potassium [Moles/volume] in Serum or Plasma4.5mmol/L3.5-5.1 mmol/LNormalS
2026-09-11Creatinine [Mass/volume] in Serum or Plasma1.1mg/dL0.74-1.35 mg/dLNormalS
2026-09-11Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M73mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-09-11Glucose [Mass/volume] in Serum or Plasma98mg/dL70-99 mg/dLNormalS
2026-09-11Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S
2026-10-16Urate [Mass/volume] in Serum or Plasma6.4mg/dL3.5-7.2 mg/dLNormalS
2026-10-16Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-10-16Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
2026-10-16Creatinine [Mass/volume] in Serum or Plasma1.09mg/dL0.74-1.35 mg/dLNormalS
2026-10-16Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M73mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-10-16Glucose [Mass/volume] in Serum or Plasma96mg/dL70-99 mg/dLNormalS
2026-10-16Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
2026-09-25Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-09-25Total score [Mini-Cog]5{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-06-12Body height173cmS
2026-06-12Body weight64kgS
2026-06-12Body mass index (BMI) [Ratio]21.4kg/m2S
2026-06-12Systolic blood pressure142mm[Hg]S
2026-06-12Diastolic blood pressure84mm[Hg]S
2026-06-12Heart rate82/minS
2026-06-12Respiratory rate16/minS
2026-06-12Body temperature36.6CelS
2026-06-12Oxygen saturation in Arterial blood by Pulse oximetry95%S
2026-06-19Body height173cmS
2026-06-19Body weight63.8kgS
2026-06-19Body mass index (BMI) [Ratio]21.3kg/m2S
2026-06-19Systolic blood pressure138mm[Hg]S
2026-06-19Diastolic blood pressure82mm[Hg]S
2026-06-19Heart rate80/minS
2026-06-19Respiratory rate16/minS
2026-06-19Body temperature36.7CelS
2026-06-19Oxygen saturation in Arterial blood by Pulse oximetry95%S
2026-07-17Body height173cmS
2026-07-17Body weight64.1kgS
2026-07-17Body mass index (BMI) [Ratio]21.4kg/m2S
2026-07-17Systolic blood pressure136mm[Hg]S
2026-07-17Diastolic blood pressure80mm[Hg]S
2026-07-17Heart rate78/minS
2026-07-17Respiratory rate16/minS
2026-07-17Body temperature36.6CelS
2026-07-17Oxygen saturation in Arterial blood by Pulse oximetry96%S
2026-09-11Body height173cmS
2026-09-11Body weight64.9kgS
2026-09-11Body mass index (BMI) [Ratio]21.7kg/m2S
2026-09-11Systolic blood pressure130mm[Hg]S
2026-09-11Diastolic blood pressure78mm[Hg]S
2026-09-11Heart rate72/minS
2026-09-11Respiratory rate14/minS
2026-09-11Body temperature36.6CelS
2026-09-11Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-10-16Body height173cmS
2026-10-16Body weight65.4kgS
2026-10-16Body mass index (BMI) [Ratio]21.9kg/m2S
2026-10-16Systolic blood pressure128mm[Hg]S
2026-10-16Diastolic blood pressure76mm[Hg]S
2026-10-16Heart rate70/minS
2026-10-16Respiratory rate14/minS
2026-10-16Body temperature36.6CelS
2026-10-16Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-09-25Body height173cmS
2026-09-25Body weight65.1kgS
2026-09-25Body mass index (BMI) [Ratio]21.8kg/m2S
2026-09-25Systolic blood pressure128mm[Hg]S
2026-09-25Diastolic blood pressure76mm[Hg]S
2026-09-25Heart rate70/minS
2026-09-25Respiratory rate14/minS
2026-09-25Body temperature36.6CelS
2026-09-25Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-07-31Body height173cmS
2026-07-31Body weight63.9kgS
2026-07-31Body mass index (BMI) [Ratio]21.4kg/m2S
2026-07-31Systolic blood pressure134mm[Hg]S
2026-07-31Diastolic blood pressure80mm[Hg]S
2026-07-31Heart rate86/minS
2026-07-31Respiratory rate18/minS
2026-07-31Body temperature37.5CelS
2026-07-31Oxygen saturation in Arterial blood by Pulse oximetry95%S

Encounters

DatePurposeStatusProvenance
2026-06-12Establishing primary care a year after his wife's death: yearning, poor sleep, low mood and withdrawal, suicide risk, heavy cigar smoking, chest tightness on hills, gout and cardiovascular riskfinishedS
2026-06-19One-week review, seen the same day by geriatric psychiatry: the diagnosis of prolonged grief disorder, grief therapy, sleep and safetyfinishedS
2026-07-17Five-week review: CT coronary angiography result, a statin and aspirin, a plan to quit smoking, and starting allopurinolfinishedS
2026-09-11Thirteen-week review: grief therapy, smoking, a gout flare while away, the urate and lipid resultsfinishedS
2026-10-16Eighteen-week review: grief, no smoking, urate toward target and his writingfinishedS
2026-09-25Subsequent annual wellness visitfinishedS
2026-07-31Same-day sick visit for a coughfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Geriatric psychiatry consultation to confirm the diagnosis, separate prolonged grief disorder from major depression, advise on grief therapy, medicine and sleep, and review suicide riskcompletedGL-APA-PGD, GL-PG13R-2021, GL-SUICIDE-2024S
Safety: a structured safety assessment, a written safety plan, the 988 Suicide & Crisis Lifeline in his phone, means safety, a telephone call in three days, and safety review at every visitcompletedGL-SUICIDE-2024, GL-BEREAVED-MEN-2004, GL-CMID-2026S
Prolonged grief disorder therapy (Shear): sixteen weekly sessions with a trained psychologist, covering the story of the death, imaginal conversations with his wife, memories and pictures, revisiting avoided places and things, and personal goals; PG-13-R and PHQ-9 every four weeks; no antidepressant unless major depression developscompletedGL-PGDT-2005, GL-PGDT-2016, GL-APA-PGD, GL-PG13R-2021S
Sleep: a fixed rising time, no naps after noon, no cigar or whisky in the last hours before bed, and getting up if awake more than twenty minutes; no benzodiazepine, zolpidem or sedating antihistaminecompletedGL-PGDT-2016, GL-CMID-2026S
Tobacco: his readiness asked at every visit; brief advice linked to his own concern about his heart; counseling at each visit and the state quitline; varenicline offered as the most effective single medicine, with combination nicotine replacement as the alternativecompletedGL-USPSTF-TOB-2021S
Chest tightness on exertion: resting ECG today and CT coronary angiography, chosen over stress testing for a man over 65 with stable symptoms and no known coronary disease; call 911 for chest pain at rest or lasting more than fifteen minutescompletedGL-CHESTPAIN-2021S
Nonobstructive coronary disease: atorvastatin 40 mg with a lipid panel 4 to 12 weeks later and a goal of at least a 50 percent fall in LDL, aspirin 81 mg, blood pressure below 130/80 mmHg, stopping smoking, and walking most dayscompletedGL-CCD-2023, GL-CMID-2026S
Gout: allopurinol from 100 mg daily, raised by 100 mg every two to five weeks to a serum urate below 6 mg/dL, with colchicine 0.6 mg daily for three to six months to prevent flares; flares treated without stopping allopurinol; HLA-B*58:01 testing not indicated by ancestry; less alcoholcompletedGL-ACR-GOUT-2020S
Social connection and his writing: one planned social contact a week, a return to morning writing on a set project, and the clinic social worker's list of local groups; meaning and goals to be part of any grief treatmentcompletedGL-PGDT-2005S
Gout: urate measured at intake; urate-lowering therapy explained, since two flares in a year make it strongly recommended; he chose to decide after the chest evaluation; call at the first sign of a flarecompletedGL-ACR-GOUT-2020S
Cardiovascular risk: blood pressure at each visit and lipids, hemoglobin A1c and kidney function at baseline; prediabetes (hemoglobin A1c 5.8 percent) managed with walking and dietcompletedGL-CMID-2026, GL-CHESTPAIN-2021S

Goals

GoalTargetStatusOutcomeProvenance
PG-13-R below 30 and back to writing and seeing friends2026-10-16completedPG-13-R 41 at intake to 26 at eighteen weeks; finishing a long essay; dinner with friends weeklyS
No thoughts of death and a safety plan he would use2026-09-11completedPassive thoughts of death at intake; none since the five-week visit; safety plan keptS
Stop smoking cigars2026-10-16activeFifteen cigars a day at intake; quit in the first week of August with varenicline; one lapse of two cigars while away; none for eight weeksS
LDL cholesterol at least 50 percent lower on a high-intensity statin2026-09-11completedLDL 150 to 74 mg/dL (51 percent lower) at eight weeksS
Serum urate below 6 mg/dL and no gout flares2026-10-16activeUrate 8.6, 7.4 and 6.4 mg/dL; one flare in August, treated while away; allopurinol raised to 300 mgS
Six or more hours of sleep on most nights without a sleeping pill2026-10-16completedAbout four to five hours at intake; six hours on most nights by eighteen weeksS

Functional Status

Mental Status

Structured synthetic safety assessment on 2026-06-12: current ideation present, intent absent, plan absent. Outpatient care with weekly visits and a telephone call in three days. Passive thoughts of death (wishing he could join his wife) without intent, plan or preparation; no past suicide attempt. Older widowed men are at high risk of suicide in the years after a loss (a Danish register study found the highest rise in suicide risk in the oldest bereaved men), and he has several further risk factors: repeated bereavement, living through the anniversary of her death, insomnia, alcohol each evening, chronic illness and social withdrawal. Means safety: no firearms in the house; medicines kept in small supplies; he agreed to keep whisky to one glass and none on bad nights. A written safety plan was made with him, and the 988 Suicide & Crisis Lifeline (call or text 988) was saved in his phone. Safety is reviewed at every visit [S]